Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.

Neisseria gonorrhoeae has consistently developed resistance to antimicrobials used therapeutically for gonorrhoea and few antimicrobials remain for effective empiric first-line therapy. Since 2009 the European gonococcal antimicrobial surveillance programme (Euro-GASP) has been running as a sentinel surveillance system across Member States of the European Union (EU) and European Economic Area (EEA) to monitor antimicrobial susceptibility in N. gonorrhoeae. During 2011, N. gonorrhoeae isolates were collected from 21 participating countries, and 7.6% and 0.5% of the examined gonococcal isolates had in vitro resistance to cefixime and ceftriaxone, respectively. The rate of ciprofloxacin and azithromycin resistance was 48.7% and 5.3%, respectively. Two (0.1%) isolates displayed high-level resistance to azithromycin, i.e. a minimum inhibitory concentration (MIC) ≥256 mg/L. The current report further highlights the public health need to implement the European response plan, including further strengthening of Euro-GASP, to control and manage the threat of multidrug resistant N. gonorrhoeae.

[1]  M. Unemo,et al.  Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.

[2]  M. Unemo,et al.  The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)—a sentinel approach in the European Union (EU)/European Economic Area (EEA) , 2013, Sexually Transmitted Infections.

[3]  M. Unemo,et al.  Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. , 2013, The Journal of antimicrobial chemotherapy.

[4]  M. Unemo,et al.  2012 European guideline on the diagnosis and treatment of gonorrhoea in adults , 2013, International journal of STD & AIDS.

[5]  I. Martin,et al.  Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. , 2013, JAMA.

[6]  M. Unemo,et al.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. , 2012, Future microbiology.

[7]  R. Kirkcaldy,et al.  Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis , 2012, Postgraduate Medical Journal.

[8]  G. Spiteri,et al.  Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  M. Unemo,et al.  The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health , 2012, Sexually Transmitted Infections.

[10]  M. Unemo,et al.  The European gonococcal antimicrobial surveillance programme, 2009. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  M. Unemo,et al.  An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. , 2011, The Journal of antimicrobial chemotherapy.

[12]  D. Lewis The Gonococcus fights back: is this time a knock out? , 2010, Sexually Transmitted Infections.

[13]  M. Unemo,et al.  Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae , 2009, Expert review of anti-infective therapy.

[14]  J. Tapsall,et al.  Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the World Health Organization Western Pacific Region, 2003. , 2005, Communicable diseases intelligence quarterly report.

[15]  M. Yasuda,et al.  Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[16]  I Lind,et al.  Antimicrobial resistance in Neisseria gonorrhoeae. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Moran Treating Uncomplicated Neisseria gonorrhoeae Infections: Is the Anatomic Site of Infection Important? , 1995, Sexually transmitted diseases.